![](/img/cover-not-exists.png)
A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11–12 months
Silfverdal, Sven-Arne, Icardi, Giancarlo, Vesikari, Timo, Flores, Sheryl A., Pagnoni, Marco F., Xu, Jin, Liu, G. Frank, Stek, Jon E., Boisnard, Florence, Thomas, Stéphane, Ziani, Eddy, Lee, Andrew W.Volume:
34
Language:
english
Journal:
Vaccine
DOI:
10.1016/j.vaccine.2016.05.054
Date:
July, 2016
File:
PDF, 393 KB
english, 2016